FDA Adverse Event Malfunction Summary report: N

BD MAX¿ ENTERIC BACTERIAL PANEL

MDR report key: 17561328 · Received August 16, 2023

Report

Report Number
3007420875-2023-00080
Event Type
Malfunction
Date Received
August 16, 2023
Date of Event
June 14, 2023
Report Date
September 11, 2023
Manufacturer
GENEOHM SCIENCES CANADA, INC. (BD DIAGNOSTICS)
Product Code
PCI
UDI-DI
00382904429638
PMA / PMN Number
K140111
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

AFTER FURTHER EVALUATION OF THE COMPLAINT, IT HAS BEEN DETERMINED THAT THE PREVIOUSLY SUBMITTED REPORT WAS SENT IN ERROR. IT WAS DETERMINED BY MANAGEMENT THAT THIS IS NOT A PRODUCT COMPLAINT, THEREFORE, THIS IS NOT CONSIDERED TO BE A REPORTABLE MALFUNCTION.

Additional Manufacturer Narrative · 0

H.3. A DEVICE EVALUATION AND/OR DEVICE HISTORY REVIEW IS ANTICIPATED BUT IS NOT COMPLETE. UPON COMPLETION, A SUPPLEMENTAL REPORT WILL BE FILED.

Description of Event or Problem · 0

REPORT 1 OF 4. IT WAS REPORTED THAT BD MAX¿ ENTERIC BACTERIAL PANEL PATIENT RESULT WAS POSITIVE FOR VIBRIO ON (B)(6) AND ON REPEAT WAS NEGATIVE. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: CUSTOMER NOTED THAT ONE PATIENT RESULT WAS POSITIVE FOR VIBRIO ON (B)(6) AND REPEATED IN DUPLICATE ON (B)(6) AND WERE NEGATIVE. ACCESSION #(B)(6), RUN#1206/1209, POSITION A9/A3 & A4, ENTERIC LOT# 3088948, EXTENDED LOT# 2355384, INITIAL RESULT VIBRIO + FINAL RESULT REPORTED VIBRIO NEG ACCESSION #(B)(6), RUN#1324/1326, POSITION A9/A1 & A2, ENTERIC LOT# 3081377, EXTENDED LOT# 3066109, INITIAL RESULT VIBRO + AND YERSINIA + FINAL RESULT REPORTED VIBRIO NEG AND YERSINIA NEG ACCESSION #(B)(6), RUN#1344/1346, POSITION A7/B5 & B6, ENTERIC LOT# 3081377, EXTENDED LOT# 3066109, INITIAL RESULT CAMPY + AND YERSINIA + FINAL RESULT REPORTED CAMPY + AND YERSINIA NEG.

Description of Event or Problem · 0

REPORT 1 OF 4 IT WAS REPORTED THAT BD MAX¿ ENTERIC BACTERIAL PANEL PATIENT RESULT WAS POSITIVE FOR VIBRIO ON JUNE 14 AND ON REPEAT WAS NEGATIVE. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: CUSTOMER NOTED THAT ONE PATIENT RESULT WAS POSITIVE FOR VIBRIO ON JUNE 14 AND REPEATED IN DUPLICATE ON JUNE 15 AND WERE NEGATIVE. ACCESSION #2316403783, RUN#1206/1209, POSITION A9/A3 & A4, ENTERIC LOT# 3088948, EXTENDED LOT# 2355384, INITIAL RESULT VIBRIO + FINAL RESULT REPORTED VIBRIO NEG ACCESSION #2321403879, RUN#1324/1326, POSITION A9/A1 & A2, ENTERIC LOT# 3081377, EXTENDED LOT# 3066109, INITIAL RESULT VIBRO + AND YERSINIA + FINAL RESULT REPORTED VIBRIO NEG AND YERSINIA NEG ACCESSION #2322001055, RUN#1344/1346, POSITION A7/B5 & B6, ENTERIC LOT# 3081377, EXTENDED LOT# 3066109, INITIAL RESULT CAMPY + AND YERSINIA + FINAL RESULT REPORTED CAMPY + AND YERSINIA NEG

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
995562 BD MAX¿ ENTERIC BACTERIAL PANEL GASTROINTESTINAL BACTERIAL PANEL MULTIPLEX NUCLEIC ACID-BASED ASSAY SYSTEM PCI GENEOHM SCIENCES CANADA, INC. (BD DIAGNOSTICS) 3088948 00382904429638

Patients

Seq Age Sex Outcome Treatment
1 Unknown